Antrogen has ranked among the top searched stocks on 6 days within the past month.

As of 1:31 PM on the 12th, Antrogen is trading at 74,700 KRW, down 3.74% from the previous day. This represents a 121.66% increase compared to May 19. Antrogen is known as a developer and seller of stem cell therapies.

Today, foreigners have a net purchase of 17,744 shares of Antrogen, and institutions have a net purchase of 2,000 shares, according to provisional data. Over the past 5 days, individual investors have net sold 18,434 shares, while foreigners and institutions have net bought 43,785 shares and net sold 26,089 shares, respectively.

On June 11, Antrogen was a market topic with a "13% increase... launch of rare disease treatment" announcement.



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing